Here’s the honest truth, we need to talk about a lot of things. Matthew McCarthy, Ben & Jerry’s CEO, has a message for CEOs who are worried about walking the talk: Don’t let fear hold you back.
But first, here’s your Bob Marley- inspired week in review, in Haiku.
Don’t worry, ‘bout a
thing, cause every little thing’s
gonna be alright!
Rose up this mornin’
smiled with the risin’ sun, with
three little birds pitch
on my heart and mind,
singin’ sweet songs, melodies
pure and true, and now
they have a message
for you (and me): One bird called
called Sweet Equity
the third bird was you! Making
We appreciate how hard you are working. Keep singing your song.
This post was originally published on Jan. 8, 2015, and was updated on March 5, 2018, Jan. 17, 2019, Jan. 30, 2020, and Jan. 15, 2021.
The above content should not be construed as legal or tax advice. Always consult an attorney or tax professional regarding your specific legal or tax situation.
When I first started my business, I was naïve about a lot of things. I treated colleagues like competition, didn’t require clients to sign contracts, and charged way too little. But I was by and far the most naïve about taxes. Quarterly estimated taxes? What are those?!
For one, I didn’t get that I was supposed to pay my taxes four times per year.
Today, almost a year after Covid-19 descended on India, we are fully cognisant of the far-reaching impact of India’s healthcare system on people’s lives, their jobs, education, economy and collective morale. What is needed is enhanced spending on healthcare. The envisaged 2.5% of GDP is still a far cry from the current 1.3% allocation. It is also imperative to address the R&D needs of the pharma sector, beyond the current Covid-19 vaccination drive.
Good afternoon, readers.
Say you walk into a hospital or other COVID vaccine distribution site. You qualify to get one because you’re a priority group under local regulations, and there are enough available doses around for you to get one. Which one would you actually receive?
The Food and Drug Administration (FDA) has already granted emergency authorization to two of them, one from Pfizer and its German partner BioNTech and the other from Moderna. But you’re unlikely to know which one of those you’ll be getting.
This pandemic has had a unifying theme: Triage. You get the resources to who needs them most. You allocate such resources accordingly. That was the case with coronavirus testing at the start of the outbreak. Now it’s the case for one of the most complex immunization campaigns in history.
While the Pfizer and Moderna vaccines share scientific roots, they’re still very different … Read the rest
Here we go again. You’d think that proliferation of direct listings and SPACs last year that enable founders, venture capitalists and big investors to take enterprises public their way would be loosening Wall Street’s grip on the IPOs––a longstanding bonanza for investment banks. But in 2020, 194 tradtional IPOs, the highest total since 2014, got done the old fashioned way, with the bankers frequently selling shares at bargain prices to their prized customers, who cleaned up from a parade of first day pops that resounded among the biggest ever. According to data posted by Jay Ritter of the University of Florida, an expert on IPOs, no fewer than 12 offerings in 2020 left $500 million or more “on the table.” In those dozen deals, the owners collected between half-a-billion and three-and-a-half billion dollars less than if they’d gotten the price where their shares settled at the close of the opening … Read the rest